Resistance to IFN-α–Induced Apoptosis Is Linked to a Loss of STAT2
Open Access
- 17 January 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 8 (1) , 80-92
Abstract
Type I IFNs (IFN-α/β) are pleitropic cytokines widely used in the treatment of certain malignancies, hepatitis B and C, and multiple sclerosis. IFN resistance is a challenging clinical problem to overcome. Hence, understanding the molecular mechanism by which IFN immunotherapy ceases to be effective is of translational importance. In this study, we report that continuous IFN-α stimulation of the human Jurkat variant H123 led to resistance to type I IFN–induced apoptosis due to a loss of signal transducers and activators of transcription 2 (STAT2) expression. The apoptotic effects of IFN-α were hampered as STAT2-deficient cells were defective in activating the mitochondrial-dependent death pathway and ISGF3-mediated gene activation. Reconstitution of STAT2 restored the apoptotic effects of IFN-α as measured by the loss of mitochondrial membrane potential, cytochrome c release from mitochondria, caspase activation, and ultimately cell death. Nuclear localization of STAT2 was a critical event as retention of tyrosine-phosphorylated STAT2 in the cytosol was not sufficient to activate apoptosis. Furthermore, silencing STAT2 gene expression in Saos2 and A375S.2 tumor cell lines significantly reduced the apoptotic capacity of IFN-α. Altogether, we show that STAT2 is a critical mediator in the activation of type I IFN–induced apoptosis. More importantly, defects in the expression or nuclear localization of STAT2 could lessen the efficacy of type I IFN immunotherapy. Mol Cancer Res; 8(1); 80–92Keywords
This publication has 46 references indexed in Scilit:
- Interferon α Induces Nucleus-independent Apoptosis by Activating Extracellular Signal-regulated Kinase 1/2 and c-Jun NH2-Terminal Kinase Downstream of Phosphatidylinositol 3-Kinase and Mammalian Target of RapamycinMolecular Biology of the Cell, 2008
- Managing chronic hepatitis C in the difficult‐to‐treat patientLiver International, 2007
- A Mutation in the SH2 Domain of STAT2 Prolongs Tyrosine Phosphorylation of STAT1 and Promotes Type I IFN-induced ApoptosisMolecular Biology of the Cell, 2007
- Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanismsCellular Signalling, 2006
- cDNA‐array profiling of melanomas and paired melanocyte culturesJournal of Cellular Physiology, 2006
- Stat1 and Stat2 but Not Stat3 Arbitrate Contradictory Growth Signals Elicited by Alpha/Beta Interferon in T LymphocytesMolecular and Cellular Biology, 2005
- Interferon α-induced Apoptosis in Tumor Cells Is Mediated through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling PathwayJournal of Biological Chemistry, 2004
- The JAK/STAT signaling pathwayJournal of Cell Science, 2004
- Identification of a Novel Conserved Motif in the STAT Family That Is Required for Tyrosine PhosphorylationJournal of Biological Chemistry, 2004
- Formation of STAT1-STAT2 Heterodimers and Their Role in the Activation of IRF-1 Gene Transcription by Interferon-αJournal of Biological Chemistry, 1996